Barrios Karen P, Connolly Dean J, Ferris Jason A, Maier Larissa J, Barratt Monica J, Winstock Adam R, Puljević Cheneal, Gilchrist Gail
National Addiction Center, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
J Psychopharmacol. 2025 Jan;39(1):8-22. doi: 10.1177/02698811241273850. Epub 2024 Oct 17.
Ketamine's popularity has surged globally in the past decade, especially among young men. Emergency department visits due to its toxicity remain relatively rare, often linked to co-occurring use of other substances.
Using data from the Global Drug Survey (GDS) 2018, this study explored the correlates associated with lifetime and past-year ketamine use, and estimated the socio-demographic characteristics, usage patterns and experiences of respondents seeking emergency medical treatment (EMT) after ketamine use.
Secondary analysis of GDS 2018, an online cross-sectional survey on drug use patterns conducted between November 2017 and January 2018.
The survey received 130,761 valid responses, with 5.93% reporting lifetime ketamine use, of which 57.70% used ketamine within the past year. Predominantly, respondents were from Germany, England and Denmark. Within the past year, 8.55% met the criteria for ketamine dependence. Respondents who used ketamine in their lifetime tended to be young (mean (x̄) = 27.37 years), men, heterosexual and of white ethnicity. Younger age (x̄ = 24.84 years), gay sexual orientation, student status, past-year use of other drugs and no lifetime mental health diagnosis were associated with past-year ketamine use. Among 4477 respondents reporting past-year ketamine use, 120 adverse events were reported, with less than 0.10% prompting EMT seeking.
The study reveals frequent ketamine use but low harm occurrence, underscoring the complex interplay between ketamine use, substance use and dependence, and related factors. This underscores the need to reassess EMT priorities, implement tailored harm reduction strategies and incorporate comprehensive screening for addressing ketamine and substance dependence challenges.
在过去十年中,氯胺酮在全球范围内的使用量激增,尤其是在年轻男性中。因氯胺酮毒性导致的急诊就诊仍然相对较少,通常与同时使用其他物质有关。
本研究利用2018年全球药物调查(GDS)的数据,探讨了与终身和过去一年氯胺酮使用相关的因素,并估计了在使用氯胺酮后寻求紧急医疗救治(EMT)的受访者的社会人口特征、使用模式和经历。
对2018年GDS进行二次分析,这是一项在2017年11月至2018年1月期间进行的关于药物使用模式的在线横断面调查。
该调查共收到130,761份有效回复,其中5.93%报告有过终身氯胺酮使用经历,其中57.70%在过去一年中使用过氯胺酮。受访者主要来自德国、英国和丹麦。在过去一年中,8.55%符合氯胺酮依赖标准。有过氯胺酮使用经历的受访者往往较年轻(平均年龄(x̄)=27.37岁),为男性,异性恋且为白人。年龄较小(x̄=24.84岁)、同性恋取向、学生身份、过去一年使用过其他药物以及无终身心理健康诊断与过去一年氯胺酮使用有关。在4477名报告过去一年使用过氯胺酮的受访者中,报告了120起不良事件,其中不到0.10%促使其寻求紧急医疗救治。
该研究表明氯胺酮使用频繁但危害发生率较低,凸显了氯胺酮使用、物质使用和依赖以及相关因素之间复杂的相互作用。这强调了重新评估紧急医疗救治优先级、实施针对性减少伤害策略以及纳入全面筛查以应对氯胺酮和物质依赖挑战的必要性。